Two Sigma Securities, LLC Palatin Technologies Inc Transaction History

Two Sigma Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.34 - $0.86 $11,784 - $29,808	-34,661 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.44 - $0.63 $15,250 - $21,836	34,661 New	34,661 $15,000
Q2 2021 Aug 16, 2021	SELL	$0.48 - $0.72 $11,003 - $16,505	-22,924 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.68 - $1.25 $15,588 - $28,655	22,924 New	22,924 $16,000
Q4 2018 Feb 14, 2019	SELL	$0.63 - $1.0 $16,624 - $26,388	-26,388 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$0.88 - $1.1 $23,221 - $29,026	26,388 New	26,388 $26,000
Q2 2018 Aug 14, 2018	SELL	$0.91 - $1.45 $35,966 - $57,309	-39,524 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$0.84 - $1.18 $33,200 - $46,638	39,524 New	39,524 $43,000
Q4 2017 Feb 14, 2018	SELL	$0.68 - $1.0 $45,251 - $66,547	-66,547 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$0.39 - $0.66 $25,953 - $43,921	66,547	66,547 $44,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.